%0 Meta-Analysis
%T Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
%A Zhou Y
%A Liu Z
%A Cheng Y
%A Li J
%A Fu W
%J J Gastrointest Surg
%V 28
%N 4
%D 2024 Apr
%M 38583910
%F 3.267
%R 10.1016/j.gassur.2024.01.023
%X <B>BACKGROUND: </B>Biliary tract cancer (BTC) is an invasive adenocarcinoma affecting the hepatobiliary system, but high recurrence rates highlight the need for more effective adjuvant approaches. The modified Glasgow prognostic score (mGPS) has been explored as an independent prognostic indicator in patients with BTC. However, consensus on its prognostic value is lacking. This meta-analysis aimed to comprehensively assess the association between mGPS and diverse clinical outcomes in BTC by systematically analyzing relevant studies.<BR><B>METHODS: </B>A systematic search approach was used to look for eligible papers published until June 2023 in PubMed, Web of Science, and Embase, with a focus on overall survival (OS) and disease-free/recurrence-free survival (DFS/RFS). The prognostic potential of mGPS was assessed using hazard ratios (HRs) with corresponding 95% CIs.<BR><B>RESULTS: </B>A total of 15 papers comprising 2447 patients were included in this meta-analysis. The results demonstrated that, in patients with BTC, the high mGPS was associated with poorer OS (HR=1.49, 95% CI=1.35-1.65, P<0.001) and DFS/RFS (HR=3.23, 95%CI=1.98-5.26, P=0.193).<BR><B>CONCLUSIONS: </B>According to this meta-analysis, our study found that high mGPS was associated with poorer OS and DFS/RFS in patients with BTC.